With effect from 14-08-2025, Mr. Sachin Mehta, Joint Managing Director has been appointed as the Chief Financial Officer and re-designated as Joint Managing Director & Chief Financial Officer ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has appointed Mr. Sachin Mehta, currently the Joint Managing Director, as the Chief Financial Officer (CFO) of the company with effect from 14 August 2025. He has been re-designated as Joint Managing Director & CFO, consolidating two top leadership roles. Mr. Mehta, aged 41, is the Founder-Promoter of the company and a relative of Mr. Hemal Mehta, the Chairman & Managing Director. This is his third stint as CFO — he previously held the role from May 2019 to October 2021 and again from December 2023 to April 2025, suggesting the previous CFO has stepped down.
Combining the CFO role with the Joint Managing Director role under a promoter-family member may raise governance concerns among minority shareholders about concentration of power and checks-and-balances at the top. Investors should watch for any clarity on succession planning and whether this internal arrangement is temporary or permanent.